Aurobindo Pharma got final approval from the US Food & Drug Administration (US FDA) to manufacture and market generic drug, Piperacillin and Tazobactam injection of varying strength packed in single use vials, the company said in a press release Tuesday.
first published: May 24, 2011 12:33 pm
A collection of the most-viewed Moneycontrol videos.
EU Ramps Up Ukraine Aid, Tomahawk Missiles as Trump-Putin Ceasefire Talks Risk Donbas Territory Loss
Samvat 2082 LIVE | Muhurat Trading LIVE | Diwali 2025 | Investment Strategies
Samvat 2082: What To Expect In The New Year | Diwali Muhurat Trading
Diwali Cheer Extends For Fourth Day| Nifty Hits 25,900 Intra-day, Banks Party| Closing Bell Live
You are already a Moneycontrol Pro user.